# Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

> **NCT05294588** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 65 (actual)

## Conditions studied

- Gonorrhea Male

## Interventions

- **DRUG:** Cefixime
- **DRUG:** Ceftriaxone
- **DRUG:** Ciprofloxacin
- **BIOLOGICAL:** Neisseria gonorrhoeae strain FA1090
- **BIOLOGICAL:** Meningococcal Group B Vaccine
- **BIOLOGICAL:** Influenza Vaccine
- **BIOLOGICAL:** Tetanus-diptheria Vaccine

## Key facts

- **NCT ID:** NCT05294588
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-18
- **Primary completion:** 2026-02-05
- **Final completion:** 2026-02-05
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05294588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05294588, "Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05294588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*